Investors will learn more about maximising opportunities arising from Queensland’s rapidly growing biotechnology industry at a special presentation at Brisbane Customs House next week.
The Health Partnerships for the Future event, hosted by UQ’s Faculty of Health Sciences, will be held on Tuesday, October 30.
The guest speaker will be Dr Robert A Fildes, Past President and CEO of Cetus Corporation and Past President and Co-Founder of Biogen Inc.
Dr Fildes will share his experiences in the US biotechnology arena, including his time with the company that discovered PCR, a technology now used in many laboratories throughout the world.
Guests from both biomedical science and financial organisations will also hear about local “Bench to Bedside” partnering opportunities from Professor Nick Fisk, Director of the new UQ Centre for Clinical Research.
As well, UQ Foundation 2006 Research Excellence Award winner, Associate Professor Greg Montieth, will identify prospective early stage research collaboration and investment ventures, such as “FLIPR’ing” out for future cancer research.
Executive Dean of UQ’s Faculty of Health Sciences, Professor Peter Brooks, said the event would highlight the health/biotech connection impacting on the economic future of Queensland.
“Partnerships between health and business enterprises hold the key to potential medical breakthroughs, many of which will shape the future of global healthcare,” Professor Brooks said.
“Our Health Partnerships for the Future showcase events make it possible for investors to establish connections with research organisations and play an important support role in influencing positive clinical outcomes.”
The event commences with refreshments from 4.30 pm in the Art Gallery at Customs House, Queen Street Brisbane. Places are limited. To reserve seats, please contact UniQuest, UQ’s main commercialisation company, before Friday 26 October by emailing rsvp@uniquest.com.au.
Media inquiries: Genevieve Giuliani, UniQuest (07 3365 4037).
